% | $
Quotes you view appear here for quick access.

VIVUS Inc. Message Board

  • normthomas432 normthomas432 Feb 2, 2013 10:17 AM Flag

    will be validated by Wall Street analysts


    These bio-techs can be tricky.
    To mention just two: DNDN & HGSI.
    Each FDA approval for what appeared to be significant therapies.
    Yet, DNDN has collapsed. From the high 40's to current valuation.
    As for HGSI, the buyout was far lower than one would have guessed.
    But additional boosting by the analysts will be beneficial for VVUS.

    This topic is deleted.
1.38+0.02(+1.47%)Nov 27 1:00 PMEST